Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Outpatient psychosocial substance use treatments for young people: An overview of reviews.

Snowdon N, Allan J, Shakeshaft A, Rickwood D, Stockings E, Boland VC, Courtney RJ.

Drug Alcohol Depend. 2019 Dec 1;205:107582. doi: 10.1016/j.drugalcdep.2019.107582. Epub 2019 Sep 25.

PMID:
31778903
2.

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.

Tutka P, Vinnikov D, Courtney RJ, Benowitz NL.

Addiction. 2019 Nov;114(11):1951-1969. doi: 10.1111/add.14721. Epub 2019 Jul 19.

PMID:
31240783
3.

A mixed methods randomised control trial to evaluate the effectiveness of the journey to social inclusion - phase 2 intervention for chronically homeless adults: study protocol.

Vallesi S, Flatau P, Thielking M, Mackelprang JL, Taylor KM, La Sala L, Spiers J, Wood L, Martin K, Kragt D, Lester L, Whittaker E, Courtney RJ.

BMC Public Health. 2019 Mar 22;19(1):334. doi: 10.1186/s12889-019-6644-1.

4.

The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.

Thomas D, Farrell M, McRobbie H, Tutka P, Petrie D, West R, Siahpush M, Gartner C, Walker N, Mendelsohn CP, Hall W, Paul C, Zwar N, Ferguson SG, Boland VC, Richmond R, Doran CM, Shakeshaft A, Mattick RP, Courtney RJ.

Addiction. 2019 May;114(5):923-933. doi: 10.1111/add.14541. Epub 2019 Feb 3.

PMID:
30589984
5.

Brief intervention on Smoking, Nutrition, Alcohol and Physical (SNAP) inactivity for smoking relapse prevention after release from smoke-free prisons: a study protocol for a multicentre, investigator-blinded, randomised controlled trial.

Jin X, Kinner SA, Hopkins R, Stockings E, Courtney RJ, Shakeshaft A, Petrie D, Dobbins T, Dolan K.

BMJ Open. 2018 Oct 18;8(10):e021326. doi: 10.1136/bmjopen-2017-021326.

6.

Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers.

Boland VC, Mattick RP, Siahpush M, Barker D, Doran CM, Martire KA, Bonevski B, McRobbie H, Borland R, Farrell M, West R, Courtney RJ.

Addict Behav. 2019 Feb;89:113-120. doi: 10.1016/j.addbeh.2018.09.029. Epub 2018 Sep 25.

PMID:
30290299
7.

The Need to Move from Describing to Evaluating the Effectiveness of Indigenous Drug and Alcohol Residential Rehabilitation Services: A Systematic Review.

James D, Shakeshaft A, Munro A, Courtney RJ.

Curr Drug Abuse Rev. 2017;10(1):52-67. doi: 10.2174/1874473711666180404123904. Review.

PMID:
29714152
9.

Smoking and finances: baseline characteristics of low income daily smokers in the FISCALS cohort.

Martire KA, Clare P, Courtney RJ, Bonevski B, Boland V, Borland R, Doran CM, Farrell M, Hall W, Iredale JM, Siahpush M, Mattick RP.

Int J Equity Health. 2017 Aug 30;16(1):157. doi: 10.1186/s12939-017-0643-6.

10.

The Methodological Quality and Effectiveness of Technology-Based Smoking Cessation Interventions for Disadvantaged Groups: A Systematic Review and Meta-analysis.

Boland VC, Stockings EA, Mattick RP, McRobbie H, Brown J, Courtney RJ.

Nicotine Tob Res. 2018 Feb 7;20(3):276-285. doi: 10.1093/ntr/ntw391.

PMID:
28034998
11.

Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers.

Courtney RJ, Clare P, Boland V, Martire KA, Bonevski B, Hall W, Siahpush M, Borland R, Doran CM, West R, Farrell M, Mattick RP.

Addict Behav. 2017 Jan;64:13-20. doi: 10.1016/j.addbeh.2016.07.019. Epub 2016 Aug 2.

PMID:
27533077
12.

Getting cytisine licensed for use world-wide: a call to action.

Walker N, Bullen C, Barnes J, McRobbie H, Tutka P, Raw M, Etter JF, Siddiqi K, Courtney RJ, Castaldelli-Maia JM, Selby P, Sheridan J, Rigotti NA.

Addiction. 2016 Nov;111(11):1895-1898. doi: 10.1111/add.13464. Epub 2016 Jul 17. No abstract available.

PMID:
27426482
13.

Associations between behavioural risk factors and smoking, heavy smoking and future smoking among an Australian population-based sample.

Iredale JM, Clare PJ, Courtney RJ, Martire KA, Bonevski B, Borland R, Siahpush M, Mattick RP.

Prev Med. 2016 Feb;83:70-6. doi: 10.1016/j.ypmed.2015.11.020. Epub 2015 Dec 2.

PMID:
26657795
14.

Targeting multiple health risk behaviours among vocational education students using electronic feedback and online and telephone support: protocol for a cluster randomised trial.

Tzelepis F, Paul CL, Wiggers J, Kypri K, Bonevski B, McElduff P, Hill MA, Morgan PJ, Lynagh M, Collins CE, Campbell E, Courtney RJ, Chapman K, Wolfenden L, Guillaumier A, Searles A.

BMC Public Health. 2015 Jun 13;15:550. doi: 10.1186/s12889-015-1898-8.

15.

Smoking Cessation among Low-Socioeconomic Status and Disadvantaged Population Groups: A Systematic Review of Research Output.

Courtney RJ, Naicker S, Shakeshaft A, Clare P, Martire KA, Mattick RP.

Int J Environ Res Public Health. 2015 Jun 8;12(6):6403-22. doi: 10.3390/ijerph120606403. Review.

16.

Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenstr├Âm's macroglobulinemia.

Xu LT, Courtney RJ, Ehlers JP.

Ophthalmic Surg Lasers Imaging Retina. 2015 Feb;46(2):262-5. doi: 10.3928/23258160-20150213-06.

17.
18.

Use of smoking cessation and quit support services by socioeconomic status over 10 years of the national drug strategy household survey.

Clare P, Slade T, Courtney RJ, Martire KA, Mattick RP.

Nicotine Tob Res. 2014 Dec;16(12):1647-55. doi: 10.1093/ntr/ntu119. Epub 2014 Oct 15.

PMID:
25320110
19.

The difference between rigor and specificity in examining methodologies for analyzing survey data: response to commentary.

Clare P, Slade T, Courtney RJ, Martire K, Mattick RP.

Nicotine Tob Res. 2014 Dec;16(12):1539-40. doi: 10.1093/ntr/ntu189. Epub 2014 Sep 19. No abstract available.

PMID:
25239963
20.

Proptosis Caused by Rhabdomyomatous Mesenchymal Hamartomata Occurring in the Orbit.

Phan IT, Courtney RJ, Marx DP, Wilson DJ, Mansoor A, Ng JD.

Ophthalmic Plast Reconstr Surg. 2016 May-Jun;32(3):e62-4. doi: 10.1097/IOP.0000000000000246.

PMID:
25105519
21.

A randomized clinical trial of a financial education intervention with nicotine replacement therapy (NRT) for low socio-economic status Australian smokers: a study protocol.

Courtney RJ, Bradford D, Martire KA, Bonevski B, Borland R, Doran C, Hall W, Farrell M, Siahpush M, Sanson-Fisher R, West R, Mattick RP.

Addiction. 2014 Oct;109(10):1602-11. doi: 10.1111/add.12669. Epub 2014 Jul 18.

PMID:
25040447
22.

The relationship between socioeconomic status and 'hardcore' smoking over time--greater accumulation of hardened smokers in low-SES than high-SES smokers.

Clare P, Bradford D, Courtney RJ, Martire K, Mattick RP.

Tob Control. 2014 Nov;23(e2):e133-8. doi: 10.1136/tobaccocontrol-2013-051436. Epub 2014 Apr 4.

PMID:
24706085
23.

Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.

Yang P, Michaels KV, Courtney RJ, Wen Y, Greninger DA, Reznick L, Karr DJ, Wilson LB, Weleber RG, Pennesi ME.

JAMA Ophthalmol. 2014 Jul;132(7):823-31. doi: 10.1001/jamaophthalmol.2014.685.

PMID:
24676353
24.

Spectral domain optical coherence tomography features in niacin maculopathy.

Courtney RJ, Singh RP.

Eye (Lond). 2014 May;28(5):629-32. doi: 10.1038/eye.2014.31. Epub 2014 Feb 28. No abstract available.

25.

Interval spectral-domain optical coherence tomography and electrophysiology findings in neonatal adrenoleukodystrophy.

Courtney RJ, Pennesi ME.

JAMA Ophthalmol. 2013 Jun;131(6):807-10. doi: 10.1001/jamaophthalmol.2013.2089. No abstract available.

PMID:
23599131
26.

Individual- and provider-level factors associated with colorectal cancer screening in accordance with guideline recommendation: a community-level perspective across varying levels of risk.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia J, McEvoy M.

BMC Public Health. 2013 Mar 20;13:248. doi: 10.1186/1471-2458-13-248.

27.

A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.

Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrae FA, D'Este C, Hill D, Barker D, Simmons J.

BMC Cancer. 2013 Jan 10;13:13. doi: 10.1186/1471-2407-13-13.

28.

Factors associated with consultation behaviour for primary symptoms potentially indicating colorectal cancer: a cross-sectional study on response to symptoms.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Attia J, McEvoy M.

BMC Gastroenterol. 2012 Aug 3;12:100. doi: 10.1186/1471-230X-12-100.

29.

Animal models of age related macular degeneration.

Pennesi ME, Neuringer M, Courtney RJ.

Mol Aspects Med. 2012 Aug;33(4):487-509. doi: 10.1016/j.mam.2012.06.003. Epub 2012 Jun 15. Review.

30.

Colorectal cancer screening in Australia: a community-level perspective.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia JR, McEvoy MA.

Med J Aust. 2012 May 7;196(8):516-20.

PMID:
22571309
31.

Colorectal cancer risk assessment and screening recommendation: a community survey of healthcare providers' practice from a patient perspective.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia J, McEvoy M.

BMC Fam Pract. 2012 Mar 14;13:17. doi: 10.1186/1471-2296-13-17.

32.

Current state of medical-advice-seeking behaviour for symptoms of colorectal cancer: determinants of failure and delay in medical consultation.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae F, Attia J, McEvoy M.

Colorectal Dis. 2012 May;14(5):e222-9. doi: 10.1111/j.1463-1318.2012.02881.x.

PMID:
22381146
33.

Inherited retinal degenerations with systemic manifestations.

Courtney RJ, Pennesi ME.

Int Ophthalmol Clin. 2012 Winter;52(1):119-47. doi: 10.1097/IIO.0b013e31823bbe56. Review. No abstract available.

PMID:
22124242
34.

Retinal dystrophy in 2 brothers with ╬▒-Mannosidosis.

Courtney RJ, Pennesi ME.

Arch Ophthalmol. 2011 Jun;129(6):799-802. doi: 10.1001/archophthalmol.2011.134. No abstract available.

PMID:
21670350
35.

Identification of interaction domains within the UL37 tegument protein of herpes simplex virus type 1.

Bucks MA, Murphy MA, O'Regan KJ, Courtney RJ.

Virology. 2011 Jul 20;416(1-2):42-53. doi: 10.1016/j.virol.2011.04.018. Epub 2011 May 20.

36.

Virion incorporation of the herpes simplex virus type 1 tegument protein VP22 is facilitated by trans-Golgi network localization and is independent of interaction with glycoprotein E.

O'Regan KJ, Brignati MJ, Murphy MA, Bucks MA, Courtney RJ.

Virology. 2010 Sep 15;405(1):176-92. doi: 10.1016/j.virol.2010.06.007. Epub 2010 Jun 26.

37.

Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model.

Olson JL, Courtney RJ, Rouhani B, Mandava N, Dinarello CA.

Ocul Immunol Inflamm. 2009 May-Jun;17(3):195-200. doi: 10.1080/09273940802710705.

PMID:
19585363
38.

The HSV-1 tegument protein pUL46 associates with cellular membranes and viral capsids.

Murphy MA, Bucks MA, O'Regan KJ, Courtney RJ.

Virology. 2008 Jul 5;376(2):279-89. doi: 10.1016/j.virol.2008.03.018. Epub 2008 May 2.

39.

Sequences in the UL11 tegument protein of herpes simplex virus that control association with detergent-resistant membranes.

Baird NL, Yeh PC, Courtney RJ, Wills JW.

Virology. 2008 May 10;374(2):315-21. doi: 10.1016/j.virol.2008.01.007. Epub 2008 Feb 7.

40.

Incorporation of the herpes simplex virus type 1 tegument protein VP22 into the virus particle is independent of interaction with VP16.

O'Regan KJ, Murphy MA, Bucks MA, Wills JW, Courtney RJ.

Virology. 2007 Dec 20;369(2):263-80. Epub 2007 Sep 20.

41.

Intravitreal infliximab and choroidal neovascularization in an animal model.

Olson JL, Courtney RJ, Mandava N.

Arch Ophthalmol. 2007 Sep;125(9):1221-4.

PMID:
17846362
42.

Herpes simplex virus type 1 tegument proteins VP1/2 and UL37 are associated with intranuclear capsids.

Bucks MA, O'Regan KJ, Murphy MA, Wills JW, Courtney RJ.

Virology. 2007 May 10;361(2):316-24. Epub 2007 Jan 16.

43.

A conserved region of the herpes simplex virus type 1 tegument protein VP22 facilitates interaction with the cytoplasmic tail of glycoprotein E (gE).

O'Regan KJ, Bucks MA, Murphy MA, Wills JW, Courtney RJ.

Virology. 2007 Feb 5;358(1):192-200. Epub 2006 Sep 25.

44.

Packaging determinants in the UL11 tegument protein of herpes simplex virus type 1.

Loomis JS, Courtney RJ, Wills JW.

J Virol. 2006 Nov;80(21):10534-41. Epub 2006 Aug 23.

45.
46.

Binding partners for the UL11 tegument protein of herpes simplex virus type 1.

Loomis JS, Courtney RJ, Wills JW.

J Virol. 2003 Nov;77(21):11417-24.

47.

Membrane association of VP22, a herpes simplex virus type 1 tegument protein.

Brignati MJ, Loomis JS, Wills JW, Courtney RJ.

J Virol. 2003 Apr;77(8):4888-98.

48.

Intracellular trafficking of the UL11 tegument protein of herpes simplex virus type 1.

Loomis JS, Bowzard JB, Courtney RJ, Wills JW.

J Virol. 2001 Dec;75(24):12209-19.

49.

Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.

Bowzard JB, Visalli RJ, Wilson CB, Loomis JS, Callahan EM, Courtney RJ, Wills JW.

J Virol. 2000 Sep;74(18):8692-9.

50.

Supplemental Content

Loading ...
Support Center